Aditya Birla Sun Life Pharma & Healthcare Fund
Portfolio as on Jul 2026 · 38 equity positions
The portfolio at a glance
Aditya Birla Sun Life Pharma & Healthcare Fund is a Sectoral / Thematic scheme from Aditya Birla SL MF. Its Jul 2026 portfolio holds 38 stocks, and its average assets under management are ₹1,076 Cr.
Its largest position is Torrent Pharmaceuticals at 9.94% of the portfolio, and the ten largest together make up 54.11%.
By sector, Pharmaceuticals & Biotechnology is the largest at 76.00% of the equity portfolio, followed by Healthcare Services (22.31%) and Insurance (0.89%).
Hold other funds too? The fund overlap tool shows how many of these stocks they share. A scheme's official riskometer is in its factsheet on the fund house's website.
NAV history
₹26.05 per unit +9.1% vs Oct '25
Last 365 days · daily NAV from AMFI · Aditya Birla Sun Life Pharma & Healthcare Fund
Performance & risk
Based on ~11 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio and alpha assume a 6.5% risk-free rate. Beta measures how much the fund moves with its benchmark (1.0 = in step); alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Past performance does not guarantee future returns — not investment advice.
Sector allocation
- Pharmaceuticals & Biotechnology76%
- Healthcare Services22%
- Insurance1%
- Chemicals & Petrochemicals1%
Top holdings
Top 10 holdings make up 54.1% of the portfolio · top 5 = 35.6%.
Aditya Birla Sun Life Pharma & Healthcare Fund — FAQ
- What are the top holdings of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund holds 38 equity positions; the largest is Torrent Pharmaceuticals Ltd at 9.94% of the portfolio, as on Jul 2026. Information only, not investment advice.
- How concentrated is Aditya Birla Sun Life Pharma & Healthcare Fund?
- Its single largest equity position is Torrent Pharmaceuticals Ltd, at 9.94% of the fund's disclosed portfolio.
- As of when is this Aditya Birla Sun Life Pharma & Healthcare Fund portfolio?
- Portfolio as on Jul 2026, taken from Aditya Birla Sun Life Mutual Fund's public monthly portfolio disclosure.
- What is the NAV of Aditya Birla Sun Life Pharma & Healthcare Fund?
- The latest NAV (Net Asset Value) of Aditya Birla Sun Life Pharma & Healthcare Fund is ₹24.88 per unit, as on Jul 2026, sourced from AMFI's public scheme data. NAV changes daily with market movements. Information only, not investment advice.
- What is the AUM of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund has a Monthly Average AUM (Assets Under Management) of ₹1,076 Cr, as per AMFI's latest published data. AUM reflects the total market value of all assets managed across all plans of this scheme. Information only, not investment advice.
- Who manages Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah, as per AMFI's public disclosure. Fund manager details sourced from Kuvera/AMFI data. Information only, not investment advice.
- What is the expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund has a Total Expense Ratio (TER) of 1.02% p.a., as disclosed to AMFI. The TER is the annual cost of running the fund, deducted daily from the NAV. A lower TER means more of the fund's return flows to investors. Information only, not investment advice.
- What is the 1-year NAV return of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund's NAV moved from ₹23.88 (Oct 2025) to ₹26.05 (Sep 2026), a change of 9.1% over approximately one year. NAV data sourced from AMFI. Past performance is not indicative of future returns. Information only, not investment advice.
- What is the Sharpe ratio of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Based on roughly 11 months of NAV history, Aditya Birla Sun Life Pharma & Healthcare Fund has an annualized return of about 10.2% with 173.3% annualized volatility, giving a Sharpe ratio of 0.02 (assuming a 6.5% risk-free rate). A higher Sharpe ratio means more return per unit of risk taken. Past performance is not indicative of future returns.
- What are the beta and alpha of Aditya Birla Sun Life Pharma & Healthcare Fund?
- Aditya Birla Sun Life Pharma & Healthcare Fund has a beta of 0.42 and an annualized alpha of +8.7%. Beta measures how much the fund moves with its benchmark — 1.0 means it moves in step, above 1.0 amplifies it. Alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Alpha assumes a 6.5% risk-free rate. The benchmark explains 23% of this fund's movement, which is low — the beta is correctly computed but says little about a fund this different from the index. Past performance is not indicative of future returns. Information only, not investment advice.
Similar funds
- ICICI Prudential Technology FundICICI Pru MF
- ICICI Prudential India Opportunities FundICICI Pru MF
- ICICI Prudential Banking & Financial Services FundICICI Pru MF
- HDFC Defence FundHDFC MF
- SBI Banking And Financial Services FundSBI MF
Equity holdings only, ISIN-verified, from Aditya Birla Sun Life Mutual Fund's public monthly portfolio disclosure (Jul 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).